Brief: Compugen To Receive Milestone Payment Triggered By Astrazeneca's Phase 2 Initiation Of Pd-1/Tigit Bispecific
16/11/2022 12:11
Nov 16 (Reuters) - Compugen Ltd CGEN.TA :
* COMPUGEN TO RECEIVE MILESTONE PAYMENT TRIGGERED BY
ASTRAZENECA'S
PHASE 2 INITIATION OF PD-1/TIGIT BISPECIFIC
* COMPUGEN LTD - CO EXPECTS TO RECEIVE A MILESTONE PAYMENT
OF $7.5
MILLION FROM ASTRAZENECA
Source text for Eikon: ID:nPn4zq4N8a
Further company coverage: CGEN.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025